Amit Maity Selected Research

T 691 (T691)

1/2003

PTEN mutation and epidermal growth factor receptor activation regulate vascular endothelial growth factor (VEGF) mRNA expression in human glioblastoma cells by transactivating the proximal VEGF promoter.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amit Maity Research Topics

Disease

42	Neoplasms (Cancer) 10/2021 - 11/2004
15	Hypoxia (Hypoxemia) 09/2017 - 11/2004
8	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 01/2003
5	Melanoma (Melanoma, Malignant) 01/2022 - 04/2015
5	Lymphoma (Lymphomas) 01/2021 - 01/2019
5	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2016
4	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 02/2007
4	Brain Neoplasms (Brain Tumor) 07/2019 - 11/2006
3	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2008
3	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2019
2	Colitis 01/2022 - 01/2021
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021 - 01/2020
2	AIDS-Related Complex (ARC) 01/2020 - 09/2015
2	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2018 - 12/2012
2	Glioma (Gliomas) 01/2018 - 02/2011
2	Carcinoma (Carcinomatosis) 12/2012 - 02/2007
1	Primary Myelofibrosis (Myelosclerosis) 01/2022
1	Radiation Injuries (Radiation Sickness) 01/2022
1	Multiple Myeloma 12/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2021
1	Inflammatory Breast Neoplasms 01/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021
1	Chronic Disease (Chronic Diseases) 01/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Dyspnea (Shortness of Breath) 01/2021
1	Fatigue 01/2021
1	Hematologic Diseases (Blood Diseases) 01/2021
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Disseminated Intravascular Coagulation 01/2020
1	Leukemia 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2019
1	Genomic Instability 01/2018
1	Infections 10/2017
1	Wounds and Injuries (Trauma) 10/2017

Drug/Important Bio-Agent (IBA)

13	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2011 - 01/2003
7	Nelfinavir (Viracept)FDA Link 01/2021 - 09/2006
6	ErbB Receptors (EGF Receptor)IBA 07/2010 - 01/2003
5	Immune Checkpoint InhibitorsIBA 01/2022 - 12/2016
4	Protons (Proton)IBA 08/2021 - 01/2019
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
4	TensinsIBA 01/2020 - 07/2006
4	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2020 - 07/2006
4	Oxygen (Dioxygen)IBA 09/2017 - 05/2005
4	Messenger RNA (mRNA)IBA 02/2011 - 01/2003
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2006
3	Biological ProductsIBA 01/2020 - 11/2009
3	HIV Protease InhibitorsIBA 10/2019 - 09/2006
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 12/2012
3	Protease Inhibitors (Protease Inhibitor)IBA 01/2014 - 11/2006
3	Pharmaceutical PreparationsIBA 09/2012 - 06/2009
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2011 - 09/2006
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2010 - 03/2006
2	SteroidsIBA 01/2022 - 01/2021
2	IpilimumabIBA 01/2022 - 01/2021
2	Prednisone (Sone)FDA LinkGeneric 01/2022 - 01/2021
2	Chimeric Antigen ReceptorsIBA 12/2021 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 10/2017
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 08/2009
2	DNA-Activated Protein KinaseIBA 01/2018 - 12/2012
2	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 01/2018 - 12/2012
2	RNA (Ribonucleic Acid)IBA 09/2017 - 02/2011
2	Temozolomide (Temodar)FDA LinkGeneric 01/2014 - 05/2007
2	dactolisibIBA 12/2012 - 09/2012
2	TOR Serine-Threonine KinasesIBA 01/2011 - 07/2006
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2009 - 01/2003
2	Small Interfering RNA (siRNA)IBA 07/2006 - 11/2004
1	fludarabineIBA 01/2022
1	Busulfan (Busulfex)FDA Link 01/2022
1	GlucocorticoidsIBA 01/2022
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 12/2021
1	B-Cell Maturation AntigenIBA 12/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	Aligeron (AS 2)IBA 01/2021
1	Human immunodeficiency virus 1 p16 proteaseIBA 01/2021
1	Rituximab (Mabthera)FDA Link 01/2021
1	Brentuximab VedotinIBA 01/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	tisagenlecleucelIBA 01/2020
1	fibrin fragment D (D-dimer)IBA 01/2020
1	axicabtagene ciloleucelIBA 01/2020
1	MicellesIBA 01/2020
1	Epirubicin (Ellence)FDA LinkGeneric 01/2020
1	Janus Kinase InhibitorsIBA 01/2020
1	Dacarbazine (DIC)FDA LinkGeneric 01/2020
1	Growth Differentiation Factor 15IBA 01/2019
1	pembrolizumabIBA 11/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Placental ExtractsIBA 10/2017
1	Protein Isoforms (Isoforms)IBA 09/2017

Therapy/Procedure

27	Radiotherapy 01/2022 - 04/2003
23	Therapeutics 01/2022 - 11/2006
9	Drug Therapy (Chemotherapy) 01/2021 - 11/2006
4	Immunotherapy 01/2022 - 11/2015
3	Proton Therapy 01/2021 - 09/2015
2	Chemoradiotherapy 10/2019 - 01/2014
1	Cell Transplantation 01/2022